Invasive breast carcinoma - IARC

3256. Zheng W, Khurana R, Farahmand S,
Wang Y, Zhang ZF, Felix JC (1998). p53
immunostaining as a significant adjunct
diagnostic method for uterine surface carcinoma:
precursor of uterine papillary
serous carcinoma. Am J Surg Pathol 22:
1463-1473.
3257. Zheng W, Wolf S, Kramer EE, Cox KA,
Hoda SA (1996). Borderline papillary
serous tumour of the fallopian tube. Am J
Surg Pathol 20: 30-35.
3258. Zhong Q, Chen CF, Li S, Chen Y, Wang
CC, Xiao J, Chen PL, Sharp ZD, Lee WH
(1999). Association of BRCA1 with the
hRad50-hMre11-p95 complex and the DNA
damage response. Science 285: 747-750.
3259. Zhou H, Kuang J, Zhong L, Kuo WL,
Gray JW, Sahin A, Brinkley BR, Sen S
(1998). Tumour amplified kinase
STK15/BTAK induces centrosome amplification,
aneuploidy and transformation. Nat
Genet 20: 189-193.
3260. Zhou X, Hampel H, Thiele H, Gorlin
RJ, Hennekam RC, Parisi M, Winter RM,
Eng C (2001). Association of germline
mutation in the PTEN tumour suppressor
gene and Proteus and Proteus-like syndromes.
Lancet 358: 210-211.
3261. Zhou XP, Kuismanen S, Nystrom-
Lahti M, Peltomaki P, Eng C (2002). Distinct
PTEN mutational spectra in hereditary
non-polyposis colon cancer syndromerelated
endometrial carcinomas compared
to sporadic microsatellite unstable tumors.
Hum Mol Genet 11: 445-450.
3262. Zhou XP, Woodford-Richens K,
Lehtonen R, Kurose K, Aldred M, Hampel
H, Launonen V, Virta S, Pilarski R,
Salovaara R, Bodmer WF, Conrad BA,
Dunlop M, Hodgson SV, Iwama T, Jarvinen
H, Kellokumpu I, Kim JC, Leggett B, Markie
D, Mecklin JP, Neale K, Phillips R, Piris J,
Rozen P, Houlston RS, Aaltonen LA,
Tomlinson IP, Eng C (2001). Germline mutations
in BMPR1A/ALK3 cause a subset of
cases of juvenile polyposis syndrome and
of Cowden and Bannayan-Riley-Ruvalcaba
syndromes. Am J Hum Genet 69: 704-711.
3263. Zhu WY, Leonardi C, Penneys NS
(1992). Detection of human papillomavirus
DNA in seborrheic keratosis by polymerase
chain reaction. J Dermatol Sci 4:
166-171.
3264. Zhu XL, Hartwick W, Rohan T, Kandel
R (1998). Cyclin D1 gene amplification and
protein expression in benign breast disease
and breast carcinoma. Mod Pathol
11: 1082-1088.
3265. Zhuang Z, Merino MJ, Chuaqui R,
Liotta LA, Emmert-Buck MR (1995).
Identical allelic loss on chromosome 11q13
in microdissected in situ and invasive
human breast cancer. Cancer Res 55: 467-
471.
3266. Ziegler RG, Hoover RN, Pike MC,
Hildesheim A, Nomura AM, West DW, Wu-
Williams AH, Kolonel LN, Horn-Ross PL,
Rosenthal JF, Hyer MB. (1993). Migration
patterns and breast cancer risk in Asian-
American women. J Natl Cancer Inst 85:
1819-1827.
3267. Zollo JD, Zeitouni NC (2000). The
Roswell Park Cancer Institute experience
with extramammary Paget's disease. Br J
Dermatol 142: 59-65.
3268. Zotalis G, Nayar R, Hicks DG (1998).
Leiomyomatosis peritonealis disseminata,
endometriosis, and multicystic mesothelioma:
an unusual association. Int J
Gynecol Pathol 17: 178-182.
3269. Zou A, Marschke KB, Arnold KE,
Berger EM, Fitzgerald P, Mais DE,
Allegretto EA (1999). Estrogen receptor
beta activates the human retinoic acid
receptor alpha-1 promoter in response to
tamoxifen and other estrogen receptor
antagonists, but not in response to estrogen.
Mol Endocrinol 13: 418-430.
3270. Zuntova A, Motlik K, Horejsi J,
Eckschlager T (1992). Mixed germ cell-sex
cord stromal tumor with heterologous
structures. Int J Gynecol Pathol 11: 227-
233.
3271. Zweemer RP, van Diest PJ, Verheijen
RH, Ryan A, Gille JJ, Sijmons RH, Jacobs
IJ, Menko FH, Kenemans P (2000).
Molecular evidence linking primary cancer
of the fallopian tube to BRCA1 germline
mutations. Gynecol Oncol 76: 45-50.
3272. Zweemer RP, Verheijen RH, Gille JJ,
van Diest PJ, Pals G, Menko FH (1998).
Clinical and genetic evaluation of thirty
ovarian cancer families. Am J Obstet
Gynecol 178: 85-90.
3273. Zwijsen RM, Wientjens E,
Klompmaker R, van der Sman J, Bernards
R, Michalides RJ (1997). CDK-independent
activation of estrogen receptor by cyclin
D1. Cell 88: 405-415.
424 References